These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 845999)

  • 1. Circulating tumor cells in murine myeloma.
    Warner TF; Moses HL; Fair DS; Krueger RG
    J Natl Cancer Inst; 1977 Apr; 58(4):983-92. PubMed ID: 845999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and viral antigens of BALB-c myeloma.
    Krueger RG; Williams WH; Miller GC
    J Natl Cancer Inst; 1974 Apr; 52(4):1203-10. PubMed ID: 4133200
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating lymphocytes and the spread of myeloma. Review of the evidence.
    Warner TF; Krueger RG
    Lancet; 1978 Jun; 1(8075):1174-6. PubMed ID: 77943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic properties of cultured tumor cell lines derived from spleens of Friend virus-infected BALB/c and BALB/c-H-2b mice.
    Freedman HA; Lilly F; Steeves RA
    J Exp Med; 1975 Dec; 142(6):1365-76. PubMed ID: 1194854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
    Haubeck HD; Kölsch E
    Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of cell-surface antigenicity of the mouse plasmacytoma. II. Lack of correlation between synthesis of myeloma protein and alteration of surface antigen.
    Ohno S; Natsu-ume-Sakai S; Migita S
    J Natl Cancer Inst; 1977 Feb; 58(2):229-37. PubMed ID: 833874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The allogeneic effect on tumor growth. II. Suppression of both ascitic and solid MOPC 315 plasmacytoma by the graft-vs-host reaction, with pathologic correlation.
    Osborne DP; Katz DH
    J Immunol; 1977 Apr; 118(4):1449-55. PubMed ID: 15035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a T suppressor cell-inducing antigenic determinant shared by ADJ-PC-5 plasmacytoma and syngeneic BALB/c spleen cells.
    Kloke O; Haubeck HD; Kölsch E
    Eur J Immunol; 1986 Jun; 16(6):659-64. PubMed ID: 2424769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1977 Mar; 58(3):701-9. PubMed ID: 300112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking effect of the migration-inhibition reaction by sera from immunized syngeneic mice and by sera from plasmacytoma-bearing BALB-c mice. Detection of free, circulating tumor antigen.
    Poupon MF; Lespinats G; Kolb JP
    J Natl Cancer Inst; 1974 Apr; 52(4):1127-34. PubMed ID: 4826584
    [No Abstract]   [Full Text] [Related]  

  • 13. The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction.
    Osborne DP; Katz DH
    J Immunol; 1977 Apr; 118(4):1441-8. PubMed ID: 15034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against MOPC-315 plasmacytoma by immunization with C-type particle preparations.
    Kleinman R; Dray S
    Cancer Res; 1978 Jan; 38(1):223-5. PubMed ID: 201375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of B-lymphocyte clonal proliferation by spleen cells from plasmacytoma-bearing mice.
    Hamburger AW
    J Natl Cancer Inst; 1980 Dec; 65(6):1337-43. PubMed ID: 6968847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals.
    Braun DP; Dray S
    Cancer Res; 1977 Nov; 37(11):4138-44. PubMed ID: 908048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary observations on immunity in BALB-c mice to myeloma tumor of BALB-c origin.
    Shearer WT; Graff RJ; Eisen HN
    Transplantation; 1972 Mar; 13(3):345-7. PubMed ID: 5021442
    [No Abstract]   [Full Text] [Related]  

  • 18. Surface markers of small lymphocytes appearing in murine TA-3(St) solid tumors, host spleen, and blood.
    Lala PK; Kaizer L
    J Natl Cancer Inst; 1977 Jul; 59(1):237-44. PubMed ID: 301572
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immunity against particulate and solubilized tumor-associated antigens of murine plasmacytomas detected by macrophage migration inhibition assays.
    Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW
    Int J Cancer; 1977 Oct; 20(4):624-31. PubMed ID: 914399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression of cell-mediated immunity in plasmacytoma-bearing mice.
    Ruszala-Mallon V; Silva J; Lumanglas AL; Durr FE; Wang BS
    Immunol Cell Biol; 1991 Feb; 69 ( Pt 1)():11-6. PubMed ID: 1831180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.